MyFinsight
Home
Blog
About
Sales and maturities
of marketable...
$29,019K
(-88.03%↓ Y/Y)
Depreciation and
amortization
$13,580K
(-70.97%↓ Y/Y)
Deposit received for the
sale of b medical...
$19,000K
Stock-based compensation
$4,812K
(-69.71%↓ Y/Y)
Accounts payable
$3,725K
(630.63%↑ Y/Y)
Net loss
$2,456K
(102.30%↑ Y/Y)
Accrued compensation
and tax...
$2,429K
(-19.30%↓ Y/Y)
Deferred income taxes
$1,735K
(108.66%↑ Y/Y)
Accrued warranty and
retrofit costs
$206K
(472.22%↑ Y/Y)
Net cash used in
investing activities
$4,724K
(105.17%↑ Y/Y)
Net cash provided by
operating activities
$1,445K
(-97.94%↓ Y/Y)
Canceled cashflow
$43,295K
Canceled cashflow
$27,498K
Net decrease in
cash, cash...
-$44,617K
(-64.19%↓ Y/Y)
Canceled cashflow
$6,169K
Purchases of marketable
securities
$36,523K
(-88.33%↓ Y/Y)
Purchases of property,
plant and equipment
$6,639K
(-74.46%↓ Y/Y)
Acquisition of uk biocentre,
net of cash acquired
$133K
Other assets and
liabilities
$7,127K
(1232.15%↑ Y/Y)
Loss on assets held
for sale
-$6,474K
(-106.96%↓ Y/Y)
Deferred revenue
-$5,155K
(-172.04%↓ Y/Y)
Accounts receivable
$4,468K
(111.52%↑ Y/Y)
Inventories
$2,801K
(-72.18%↓ Y/Y)
Inventory write-downs and
other non-cash items
-$582K
(-115.05%↓ Y/Y)
Accrued restructuring
costs
-$480K
(-841.18%↓ Y/Y)
Amortization and accretion on
marketable securities
$406K
(-69.20%↓ Y/Y)
Loss on disposals of
property, plant and...
$5K
(100.66%↑ Y/Y)
Net cash used in
financing activities
-$50,320K
(-383.47%↓ Y/Y)
Effects of exchange rate
changes on cash, cash...
-$466K
(-110.33%↓ Y/Y)
Share repurchases
$50,046K
Payments of finance
leases
$172K
(-70.60%↓ Y/Y)
Withholding tax payments on
net share...
$101K
Proceeds from issuance of
common stock
-$1K
(-100.06%↓ Y/Y)
Back
Back
Cash Flow
Azenta, Inc. (AZTA)
Azenta, Inc. (AZTA)
source: myfinsight.com